• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

Phathom

















the hiring manager I spoke to said they were going to meet more as districts or regions and then wait to do a big national sales meeting in late spring or early summer. said that way we wouldn't be pulled out of the field while trying to gain traction
 












































Keep job searching even if you landed a spot here. We were unsuccessful bringing this drug to market on multiple occasions, don't get your hopes up that it will be any different this time.